Einträge von Engert, Andreas auf dem Publikationsserver

Grund, Johanna, Iben, Katharina, Reinke, Sarah, Bühnen, Ina, Plütschow, Annette, Müller‐Meinhard, Berit, Garcia Marquez, Maria A., Schlößer, Hans A., von Tresckow, Bastian , Kellermeier, Fabian, Borchmann, Peter, Engert, Andreas, Bröckelmann, Paul J. und Klapper, Wolfram (2023) Low B‐cell content is associated with a CD73‐low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma. British Journal of Haematology 201 (6), S. 1097-1102. Volltext nicht vorhanden.

Jachimowicz, Ron D., Klapper, Wolfram, Glehr, Gunther , Müller, Horst, Haverkamp, Heinz, Thorns, Christoph, Hansmann, Martin Leo, Möller, Peter, Stein, Harald, Rehberg, Thorsten, von Tresckow, Bastian, Reinhardt, H. C., Borchmann, Peter, Chan, Fong Chun, Spang, Rainer, Scott, David W., Engert, Andreas, Steidl, Christian, Altenbuchinger, Michael und Rosenwald, Andreas (2021) Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. Leukemia.

Böll, Boris, Plütschow, Annette, Bürkle, Carolin, Atta, Johannes, Pfreundschuh, Michael, Feuring‐Buske, Michaela, Vogelhuber, Martin, Sökler, Martin, Eichenauer, Dennis A., Thielen, Indra, Tresckow, Bastian, Fuchs, Michael, Engert, Andreas und Borchmann, Peter (2019) Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group ( GHSG ) phase‐I trial. British Journal of Haematology 185 (1), S. 42-52. Volltext nicht vorhanden.

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schäfer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josée M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Dührsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter und Engert, Andreas (2019) Positron Emission Tomography–Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. Journal of Clinical Oncology 37 (31), S. 2835-2845. Volltext nicht vorhanden.

Engert, Andreas und Hornuf, Lars (2018) Market Standards in Financial Contracting: The Euro’s Effect on Choice of Law in European Debt Securities. Journal of International Money and Finance 85, S. 145-162.

Eidenmüller, Horst, Engert, Andreas und Hornuf, Lars (2015) Where Do Firms Issue Debt? An Empirical Analysis of Issuer Location and Regulatory Competition in the European Corporate Debt Market. International Review of Law and Economics 41, S. 103-115. Volltext nicht vorhanden.

Behringer, Karolin, Goergen, Helen, Hitz, Felicitas, Zijlstra, Josée M, Greil, Richard , Markova, Jana, Sasse, Stephanie, Fuchs, Michael, Topp, Max S, Soekler, Martin, Mathas, Stephan, Meissner, Julia, Wilhelm, Martin, Koch, Peter, Lindemann, Hans-Walter, Schalk, Enrico, Semrau, Robert, Kriz, Jan, Vieler, Tom, Bentz, Martin, Lange, Elisabeth, Mahlberg, Rolf, Hassler, Andre, Vogelhuber, Martin, Hahn, Dennis, Mezger, Jörg, Krause, Stefan W , Skoetz, Nicole, Böll, Boris, von Tresckow, Bastian, Diehl, Volker, Hallek, Michael, Borchmann, Peter, Stein, Harald, Eich, Hans und Engert, Andreas (2015) Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. The Lancet 385 (9976), S. 1418-1427. Volltext nicht vorhanden.

Braun, Rainer, Eidenmüller, Horst, Engert, Andreas und Hornuf, Lars (2013) Does Charter Competition Foster Entrepreneurship? A Difference-in-Difference Approach to European Company Law Reforms. Journal of Common Market Studies 51 (3), S. 399-415. Volltext nicht vorhanden.

Engert, Andreas, Haverkamp, Heinz, Kobe, Carsten, Markova, Jana, Renner, Christoph, Ho, Antony, Zijlstra, Josée, Král, Zdenek, Fuchs, Michael, Hallek, Michael, Kanz, Lothar, Döhner, Hartmut, Dörken, Bernd, Engel, Nicole, Topp, Max, Klutmann, Susanne, Amthauer, Holger, Bockisch, Andreas, Kluge, Regine, Kratochwil, Clemens, Schober, Otmar, Greil, Richard , Andreesen, Reinhard, Kneba, Michael, Pfreundschuh, Michael, Stein, Harald, Eich, Hans Theodor, Müller, Rolf-Peter, Dietlein, Markus, Borchmann, Peter und Diehl, Volker (2012) Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. The Lancet 379 (9828), S. 1791-1799. Volltext nicht vorhanden.

Engert, Andreas, Josting, Andreas, Haverkamp, Heinz, Villalobos, Matthias, Lohri, Andreas, Sökler, Martin, Zijlstra, Josée, Sturm, Isrid, Topp, Max S., Rank, Andreas, Zenz, Thorsten, Vogelhuber, Martin, Nogova, Lucia, Borchmann, Peter, Fuchs, Michael, Flechtner, Hans-Henning und Diehl, Volker (2010) Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial. Journal of Clinical Oncology 28 (13), S. 2239-2245. Volltext nicht vorhanden.

Schmidt-Wolf, Ingo G.H., Pels, Hendrick, Jurgens, Annika, Glasmacher, Axel, Schulz, Holger, Engert, Andreas, Linnebank, Michael, Schackert, Gabriele, Reichmann, Heinz, Kroschinsky, Frank, Vogt-Schaden, Marlies, Egerer, Gertlinde, Schaller, Carlo, Lamprecht, Monika, Bogdahn, Ulrich, Deckert, Martina, Fimmers, Rolf, Bangard, Christoph und Schlegel, Uwe (2007) Early Relapses in Primary CNS Lymphoma (PCNSL) without Intraventricular Treatment. Blood 110 (11), S. 4440. Volltext nicht vorhanden.